Iron preparation

PreclinicalSmall molecule

HHaEmek Medical Center, Israel

Iron preparation is one of 19 small molecule programs targeting Metabolism. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MetabolismUnknown status

MetabolismPreclinical

Unknown status

Competition

Competitive Landscape

26 competitors in Metabolism

#DrugCompanyPhaseTrials

Ethanol

Roche

Phase 3

1 2

Cymbalta

Jazz Pharmaceuticals

Phase 1

2 3

Bayer Aspirin

Bayer

Phase 1

1 4

Rapamycin

MMaastricht Radiation Oncology

Phase 2

1 5

Tasmar

BBausch Health Americas, Inc.

Phase 1

1 6

Atropen

FFresenius Kabi Taiwan Ltd.

Phase 1

1 7

Exendin-(9-39)

EEiger BioPharmaceuticals

Phase 1

3 8

Obicetrapib

NNewAmsterdam Pharma

Phase 1

1 9

Quemliclustat

Arcus Biosciences

Phase 1

1 10

Dilantin

VViatris Specialty LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Metabolism1 trial

Iron Metabolism in Small Pre Term Newborns

Unknown status·HHaEmek Medical Center, Israel·N/A·NCT01443195·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Iron preparation. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Iron preparation compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Iron preparation. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — HaEmek Medical Center, Israel company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: HHaEmek Medical Center, Israel

Iron preparation

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Metabolism1 trial

References

Drug Info

Quick Facts

Related News